Asia–Pacific Journal of Clinical Oncology is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia–Pacific region in relation to cancer treatment and care. The Journal is ideally positioned to receive publications that deal with diversity in cancer behavior, management and outcome related to ethnic, cultural, economic and other differences between populations. In addition to original articles, the Journal publishes reviews, editorials, letters to the Editor and short communications. Case reports are generally not considered for publication, only exceptional papers in which Editors find extraordinary oncological value may be considered for review. The Journal encourages clinical studies, particularly prospectively designed clinical trials. Asia–Pacific Journal of Clinical Oncology是一本多学科肿瘤学期刊,旨在成为促进亚太地区不同国家癌症治疗和护理领域合作与交流的论坛。 该期刊发表存在种族、文化、经济和其他差异的人群之间在癌症行为、管理和治疗效果方面的多样性的文章。除原创文章外,该期刊还发表综述、社论、致编辑的信以及短文。病例报告一般不考虑发表,只有编辑们认为具有非凡肿瘤学价值的特殊论文,才会考虑予以审核。该期刊欢迎关于临床研究的稿件,特别是关于具有前瞻性设计的临床试验的稿件。
《亚太临床肿瘤学杂志》是一本多学科肿瘤学杂志,旨在成为一个论坛,促进亚太地区不同国家在癌症治疗和护理方面的合作和信息交流。该杂志是理想的定位,以接收出版物,处理多样性的癌症行为,管理和结果有关的种族,文化,经济和其他差异之间的人口。除了原创文章外, 《日刊》还发表评论、社论、致编辑的信和简短通讯。病例报告通常不考虑发表,只有编辑发现具有非凡肿瘤学价值的例外论文才考虑进行审查。该杂志鼓励临床研究,特别是前瞻性设计的临床试验。
Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection
来源期刊:Asia-Pacific Journal of Clinical OncologyDOI:10.1111/ajco.13050
A prognostic nomogram constructed for relapsed or refractory diffuse large B-cell lymphoma patients.
来源期刊:Asia-Pacific journal of clinical oncologyDOI:10.1111/ajco.13222
Stereotactic body radiation therapy for oligometastatic pulmonary tumors from cervical cancer
来源期刊:Asia-Pacific Journal of Clinical OncologyDOI:10.1111/ajco.13159
A phase I/II trial of weekly nab‐paclitaxel for pretreated non‐small‐cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement
来源期刊:Asia-Pacific Journal of Clinical OncologyDOI:10.1111/ajco.13147
When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival.
来源期刊:Asia-Pacific journal of clinical oncologyDOI:10.1111/ajco.13287
Phase II APEC trial: The impact of primary tumor side on outcomes of first‐line cetuximab plus FOLFOX or FOLFIRI in patients with RAS wild‐type metastatic colorectal cancer
来源期刊:Asia-Pacific Journal of Clinical OncologyDOI:10.1111/ajco.13154
A multicenter observational study of the real‐world use of docetaxel for metastatic castration‐resistant prostate cancer in China
来源期刊:Asia-Pacific Journal of Clinical OncologyDOI:10.1111/ajco.13142
Androgen deprivation therapy in nonmetastatic prostate cancer patients: Indications, treatment effects, and new predictive biomarkers
来源期刊:Asia-Pacific Journal of Clinical OncologyDOI:10.1111/ajco.13108
Axillary dissection in sentinel lymph node positive breast cancer: Is the staging information worthwhile for patients?
来源期刊:Asia-Pacific journal of clinical oncologyDOI:10.1111/ajco.13238
Cost-effective analysis of supervised exercise training in men with prostate cancer previously treated with androgen deprivation therapy and radiation
来源期刊:Asia-pacific Journal of Clinical OncologyDOI:10.1111/AJCO.13262
Partial chest wall radiation therapy for positive or close surgical margins after modified radical mastectomy for breast cancer without lymph node metastasis
来源期刊:Asia-Pacific Journal of Clinical OncologyDOI:10.1111/ajco.13276
Improved gut integrity in female breast cancer survivors after a 12-week exercise intervention
来源期刊:Asia-pacific Journal of Clinical OncologyDOI:10.1111/AJCO.13263